$0.7283
-0.0357-4.67%
Last update: Nov 9, 10:28 AM
Dermata Therapeutics Inc
DRMANASDAQ
The average analyst price target for Dermata Therapeutics is $10, 1273.1% above the current price. The one analyst covering it rates it Buy. The latest change came on Aug 21, 2025, when Maxim Group lowered its price target on Dermata Therapeutics from $30 to $10 and kept a Buy rating.
Price Target Range — 3 Quarters
Analyst Consensus — 1 Analysts
Rating Trend — Last 9 Months
